Announcement • Mar 17
Astrid Intelligence Plc, Annual General Meeting, Apr 17, 2026 Astrid Intelligence Plc, Annual General Meeting, Apr 17, 2026. Location: the offices of fladgate llp, 16 great queen street, london, wc2b 5dg United Kingdom Announcement • Mar 11
Astrid Intelligence Plc (OFEX:ASTR) acquired Validator of Bittensor network. Astrid Intelligence Plc (OFEX:ASTR) acquired Validator of Bittensor network on March 10, 2026.
This acquisition allows Astrid to operate the validator under the Astrid Validator brand, enhancing its participation and governance role within the Bittensor network.
Astrid Intelligence Plc (OFEX:ASTR) completed the acquisition of Validator of Bittensor network on March 10, 2026. Announcement • Mar 07
Astrid Intelligence plc Announces Termination of Ms Olivia Edwards as Director, Effective March 4, 2026 Astrid Intelligence Plc announced the termination of the appointment of Ms Olivia Edwards as director, effective March 4, 2026. Announcement • Mar 06
Astrid Intelligence plc Announces the Launch of Astrid Vault Astrid Intelligence Plc announce the launch of Astrid Vault, a new on-chain platform designed with the aim of improving liquidity and stability across the Bittensor AI network. Within decentralised AI networks, each subnet has its own token. When holders of these tokens want to exit positions, selling into open markets can create short-term price pressure and volatility. Astrid Vault has been developed to potentially serve as an alternative mechanism for long-term participation, which could help mitigate this short-term disruption. Holders of any subnet tokens can choose to deposit their tokens into Astrid Vault for a long-term lock-up period. The deposited tokens remain locked for an extended duration, helping to reduce immediate selling pressure and support more orderly market conditions across subnets. In return, they receive a discounted amount of Astrid's Subnet 127 tokens, subject to pre-defined, algorithmic parameters which the user can choose to sell or keep. All allocations are governed transparently by on-chain rules. The Company believes that the Astrid Vault may strengthen the Company's role as a liquidity coordination and infrastructure provider within the Bittensor ecosystem. By facilitating structured and long-term token commitments the Company: Deepens its integration within multiple subnets; Improves network stability support through reduced short-term volatility; expands its operational footprint across the ecosystem; and attracts and locks up more subnet tokens than it emits. The Board believes that practical infrastructure solutions which improve coordination and stability will likely become increasingly important as decentralised AI networks continue to grow. Further updates, including adoption metrics, will be provided in due course. Announcement • Jan 20
Astrid Intelligence Plc (OFEX : ASTR) acquired TaoFi. Astrid Intelligence Plc (OFEX : ASTR) acquired TaoFi on January 20, 2026. The consideration is paid in TAO tokens from the Astrid Intelligence Plc's existing reserves. Following the acquisition, TaoFi will be renamed as Astrid Bridge and operated as part of Astrid's growing suite of decentralised infrastructure assets.
Astrid Intelligence Plc (OFEX : ASTR) completed the acquisition of TaoFi on January 20, 2026. Announcement • Aug 01
Cel AI PLC Announces Intention to Cancel Listing on London Stock Exchange Cel AI PLC announced its intention to cancel: (i) the listing of the Company's Ordinary Shares ("Ordinary Shares") on the Equity Shares (Transition) category of the Official List (the "Official List") of the U.K. Financial Conduct Authority ("FCA"); and (ii) the admission to trading of its Ordinary Shares on the London Stock Exchange's ("LSE") main market for listed securities (together, the "Delisting"). As per the Company's articles of association, shareholder approval is required for the Delisting. In accordance with U.K. Listing Rule 21.2.17R, the Company is required to give at least 20 business days' notice of the Delisting. As such, conditional on the Resolutions being passed at the General Meeting, it is intended that the Delisting will become effective from 8:00 a.m. (U.K. time) on 1 September 2025, such that the last day of trading of the Ordinary Shares on the LSE will be 29 August 2025. The Company notes that the move to AQSE Growth Market is necessary in order to continue with the Bitcoin strategy which will become impracticable under the Listing Rules. Accordingly, the Directors will recommend that Shareholders vote in favour of the Resolutions at the General Meeting. Cel AI's current holding in Bitcoin remains at 5.28 BTC following a disposal of 3.42 BTC on 17 July 2025. The Company intends to continue to acquire further Bitcoin following admission to the AQSE Growth Market. New Risk • Jul 29
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 8x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (36% average weekly change). Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Revenue is less than US$1m (UK£1.0 revenue, or US$1.0). Minor Risk Market cap is less than US$100m (UK£10.1m market cap, or US$13.4m). Announcement • Jul 02
Cel AI PLC has completed a Follow-on Equity Offering in the amount of £10 million. Cel AI PLC has completed a Follow-on Equity Offering in the amount of £10 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 5,000,000,000
Price\Range: £0.002
Transaction Features: Subsequent Direct Listing Announcement • Jun 03
Cel AI PLC has completed a Follow-on Equity Offering in the amount of £0.25 million. Cel AI PLC has completed a Follow-on Equity Offering in the amount of £0.25 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 39,062,500
Price\Range: £0.0064 New Risk • May 28
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 37% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (34% average weekly change). Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (37% increase in shares outstanding). Revenue is less than US$1m (UK£18k revenue, or US$24k). Market cap is less than US$10m (UK£4.86m market cap, or US$6.55m). Announcement • Jan 31
Cel AI PLC, Annual General Meeting, Feb 25, 2025 Cel AI PLC, Annual General Meeting, Feb 25, 2025. Location: the offices of fladgate llp, 16 great queen street, wc2b 5dg, london United Kingdom Reported Earnings • Dec 31
Full year 2024 earnings released: UK£0.003 loss per share (vs UK£0.006 loss in FY 2023) Full year 2024 results: UK£0.003 loss per share (improved from UK£0.006 loss in FY 2023). Net loss: UK£1.83m (loss narrowed 45% from FY 2023). New Risk • Dec 15
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended February 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (26% average weekly change). Earnings have declined by 25% per year over the past 5 years. Revenue is less than US$1m (UK£54k revenue, or US$68k). Market cap is less than US$10m (UK£361.4k market cap, or US$456.0k). Minor Risk Latest financial reports are more than 6 months old (reported February 2024 fiscal period end). New Risk • Dec 04
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 25% per year over the past 5 years. Revenue is less than US$1m (UK£54k revenue, or US$69k). Market cap is less than US$10m (UK£212.0k market cap, or US$269.4k). Announcement • Jun 15
Cel AI PLC Appoints Timothy Le Druillenec as Executive Director Cel AI PLC announce that Timothy Le Druillenec has been appointed as Executive Director. The appointment will take effect immediately. Timothy Le Druillenec is a qualified Accountant and has acted as a director and company secretary to a number of public and private companies over many years and held main board positions on several Main Market, AIM, PLUS and Aquis companies. He has been involved with launching several companies on the Main Market of the London Stock Exchange in the cinema, home shopping, property, esports and crypto sectors. He is currently a Director of Phoenix Digital Assets Plc as well as some private companies. Current directorships and/or partnerships: Aquis Stock Exchange listed company: Phoenix Digital Assets PLC, Private: - Briarmount Limited - Venn It Systems Limited - Pllugs Limited - IO+ PTE LTD. Former directorships and/or partnerships (within the last five years): Aquis Stock Exchange listed companies: Supernova Digital Assets PLC - File Forge Technology PLC - Motto Technologies PLC - Googly Esports PLC - Punter Finance PLC. London Stock Exchange listed companies: Argo Blockchain PLC - Guild Esports PLC - Streaks AI PLC Private: Bent Tree Estates Limited. Announcement • Apr 30
Cel AI PLC Ceases Gill Whitty Collins as Non-Executive Director Cel AI announced that the Company and Gill Whitty Collins have agreed that Gill will cease to be a Non-Executive Director of the Company with effect from 30 April 2024, being the end of her fixed-term engagement with the Company. New Risk • Mar 10
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: UK£364k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.6m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (UK£67k revenue, or US$86k). Market cap is less than US$10m (UK£2.11m market cap, or US$2.71m). Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Significant insider selling over the past 3 months (UK£364k sold). Announcement • Jan 19
Cellular Goods PLC, Annual General Meeting, Feb 13, 2024 Cellular Goods PLC, Annual General Meeting, Feb 13, 2024, at 14:00 Coordinated Universal Time. Location: Fladgate LLP at 16 Great Queen Street London: United Kingdom Reported Earnings • Dec 23
Full year 2023 earnings released: UK£0.006 loss per share (vs UK£0.012 loss in FY 2022) Full year 2023 results: UK£0.006 loss per share (improved from UK£0.012 loss in FY 2022). Net loss: UK£3.31m (loss narrowed 45% from FY 2022). Announcement • Dec 05
Cellular Goods plc Launches Luxury Gift Sets for the Christmas Season Cellular Goods plc announced the launch of its 'Look Better' skincare range festive gift sets for the Christmas season. The 'Gift Better' collection comprises the Nourish and Relax Gift Set, containing Cellular Goods' Cannabinoid Face Oil, a camomile and lavender scented candle, a luxury silk sleeping eye mask and a vegan leather reusable bag. Also available for purchase is the Rejuvenate and Indulge Gift Set, containing cellular Goods' Cannabinoid Face Serum and the Rejuvenating Night Cream, a camomile and Lavender scented candle, a Lux silk sleeping eye mask and a Vegan leather reusable vanity bag. The 'Gift Better range adds festive gifting options to the Company's gift set repertoire that already includes the Rejuvenate and Unwind, and Calm and Balance Gift Sets. New Risk • Nov 24
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended February 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£4.5m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 58% per year over the past 5 years. Revenue is less than US$1m (UK£47k revenue, or US$59k). Market cap is less than US$10m (UK£2.71m market cap, or US$3.40m). Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Shareholders have been diluted in the past year (19% increase in shares outstanding). New Risk • Oct 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£4.5m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 58% per year over the past 5 years. Revenue is less than US$1m (UK£47k revenue, or US$57k). Market cap is less than US$10m (UK£3.23m market cap, or US$3.94m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding). Announcement • May 10
Cellular Goods PLC (LSE:CBX) acquired King Tide Carbon PTE. LTD from Matthew Lodge for £0.57 million. Cellular Goods PLC (LSE:CBX) acquired King Tide Carbon PTE. LTD from Matthew Lodge for £0.57 million on May 5, 2023. As a part of the transaction, Matthew Lodge is appointed as a non-executive director of the Cellular Goods and remains part of founding team of King Tide. First Sentinel Corporate Finance Limited acted as financial advisor to Cellular Goods PLC.
Cellular Goods PLC (LSE:CBX) completed the acquisition of King Tide Carbon PTE. LTD from Matthew Lodge on May 5, 2023. Board Change • May 08
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CFO, Company Secretary & Director Bruna Nikolla was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Feb 10
Cannaray Brands Limited/Love CBD Health LTD cancelled the acquisition of Cellular Goods PLC (LSE:CBX). Cannaray Brands Limited/Love CBD Health LTD agreed to acquire Cellular Goods PLC (LSE:CBX)for £14.2 million on September 26, 2022. Cannaray Limited will appoint the majority of the ongoing CBX board of directors. Cellular Goods has conditionally agreed to acquire the Cannaray Subsidiaries for an initial consideration of £14.2 million, consisting of £1 million in cash, together with a number of new Cellular shares, which will make Cannaray a 54% shareholder in the enlarged group. There can be no certainty that the Transaction will proceed and it remains subject to, amongst other things, entering into a definitive legal agreement and obtaining all other necessary approvals.
Cannaray Brands Limited/Love CBD Health LTD cancelled the acquisition of Cellular Goods PLC (LSE:CBX) on February 8, 2023. Announcement • Jan 20
Cellular Goods PLC, Annual General Meeting, Feb 13, 2023 Cellular Goods PLC, Annual General Meeting, Feb 13, 2023, at 16:00 Coordinated Universal Time. Location: the offices of Fladgate LLP 16 Great Queen Street, London, WC2B 5DG London United Kingdom Announcement • Jan 07
Cellular Goods plc Announces Board Changes produced cannabinoids, announced that Peter Wall and Simon Walters, non-executive directors, have stepped down from the Board of Directors and are leaving the Company with immediate effect. Mr. Wall has stepped down to focus on pre-existing executive management positions. Mr. Walters' retirement from the Board as a NED follows Cellular's planned course of business, with Mr. Walters having served on the Board as Finance Director since November 2020. The role held by Simon changed to Non-Executive Director in September 2022 to coincide with Cellular's appointment of Bruna Nikolla as Chief Financial Officer.Following these departures, the composition of the Board is as follows: Darcy Taylor is Interim CEO and Chairman, Bruna Nikolla is Chief Financial Officer; and Misha Sher and Gill Whitty-Collins are Non-Executive Directors. Board Change • Nov 16
No independent directors There are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). Chief Strategy Officer & Director Alexis Abraham is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors. Board Change • Apr 27
No independent directors There are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). Chief Strategy Officer & Director Alexis Abraham is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors. Recent Insider Transactions • Oct 06
CEO & Director recently bought UK£155k worth of stock On the 1st of October, Alexis Abraham bought around 2m shares on-market at roughly UK£0.077 per share. This was the largest purchase by an insider in the last 3 months. This was Alexis' only on-market trade for the last 12 months.